HERON THERAPEUTICS, INC. /DE/ Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Heron Therapeutics, Inc. /De/ quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2010 to Q3 2024.
  • Heron Therapeutics, Inc. /De/ Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$1.92B, a 1.48% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$1.92B -$28M -1.48% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$1.92B -$48.1M -2.57% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$1.91B -$81M -4.43% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1.91B -$111M -6.16% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 -$1.9B -$120M -6.74% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$1.87B -$137M -7.88% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$1.83B -$151M -9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$1.8B -$182M -11.3% Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$1.78B -$217M -13.9% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$1.73B -$227M -15.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$1.68B -$232M -16% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$1.61B -$221M -15.8% Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$1.56B -$228M -17.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 -$1.51B -$234M -18.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$1.45B -$228M -18.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 -$1.39B -$227M -19.5% Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$1.33B -$223M -20.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$1.27B -$198M -18.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$1.22B -$193M -18.9% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$1.17B -$205M -21.3% Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$1.11B -$196M -21.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$1.07B -$201M -23% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 -$1.02B -$190M -22.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$961M -$177M -22.6% Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$911M -$190M -26.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$873M -$194M -28.5% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$834M -$198M -31.1% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$783M -$197M -33.7% Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$721M -$183M -34% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 -$679M -$190M -38.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$636M -$190M -42.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$586M -$173M -41.9% Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$538M -$156M -41% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$489M -$131M -36.4% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 -$446M -$110M -32.9% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 -$413M -$97.6M -31% Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$382M -$87M -29.5% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$359M -$83.5M -30.3% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 -$336M -$79.4M -31% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 -$315M -$76.4M -32% Dec 31, 2014 10-K 2016-02-19
Q3 2014 -$295M -$69.8M -31% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 -$275M -$63.5M -29.9% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 -$256M -$59.9M -30.5% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 -$239M -$55.3M -30.1% Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$225M -$49M -27.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 -$212M -$42.2M -24.9% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 -$197M -$31.4M -19% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 -$184M -$23.3M -14.6% Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$176M -$19.9M -12.7% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 -$170M -$18M -11.8% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 -$165M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 -$160M -$11.8M -7.96% Dec 31, 2011 10-K 2013-03-01
Q3 2011 -$156M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 -$152M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 -$148M Dec 31, 2010 10-K 2012-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.